303 related articles for article (PubMed ID: 16872093)
21. EUD-based radiotherapy treatment plan evaluation: incorporating physical and Monte Carlo statistical dose uncertainties.
Cranmer-Sargison G; Zavgorodni S
Phys Med Biol; 2005 Sep; 50(17):4097-109. PubMed ID: 16177533
[TBL] [Abstract][Full Text] [Related]
22. Optimization of equivalent uniform dose using the L-curve criterion.
Chvetsov AV; Dempsey JF; Palta JR
Phys Med Biol; 2007 Oct; 52(19):5973-84. PubMed ID: 17881813
[TBL] [Abstract][Full Text] [Related]
23. Linear quadratic and tumour control probability modelling in external beam radiotherapy.
O'Rourke SF; McAneney H; Hillen T
J Math Biol; 2009 Apr; 58(4-5):799-817. PubMed ID: 18825382
[TBL] [Abstract][Full Text] [Related]
24. Patient-specific dosimetry of conventional and intensity modulated radiation therapy using a novel full Monte Carlo phase space reconstruction method from electronic portal images.
Jarry G; Verhaegen F
Phys Med Biol; 2007 Apr; 52(8):2277-99. PubMed ID: 17404469
[TBL] [Abstract][Full Text] [Related]
25. Dose-volume conundrum for response of prostate cancer to brachytherapy: summary dosimetric measures and their relationship to tumor control probability.
D'Souza WD; Thames HD; Kuban DA
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1540-8. PubMed ID: 15050335
[TBL] [Abstract][Full Text] [Related]
26. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
Luxton G; Hancock SL; Boyer AL
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
[TBL] [Abstract][Full Text] [Related]
27. A TCP model incorporating setup uncertainty and tumor cell density variation in microscopic extension to guide treatment planning.
Jin JY; Kong FM; Liu D; Ren L; Li H; Zhong H; Movsas B; Chetty IJ
Med Phys; 2011 Jan; 38(1):439-48. PubMed ID: 21361212
[TBL] [Abstract][Full Text] [Related]
28. The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies.
van Leeuwen CM; Oei AL; Crezee J; Bel A; Franken NAP; Stalpers LJA; Kok HP
Radiat Oncol; 2018 May; 13(1):96. PubMed ID: 29769103
[TBL] [Abstract][Full Text] [Related]
29. Consequences of dose heterogeneity on the biological efficiency of ¹⁰³Pd permanent breast seed implants.
Afsharpour H; Reniers B; Landry G; Pignol JP; Keller BM; Verhaegen F; Beaulieu L
Phys Med Biol; 2012 Feb; 57(3):809-23. PubMed ID: 22252246
[TBL] [Abstract][Full Text] [Related]
30. Tumor dosimetry in radioimmunotherapy: methods of calculation for beta particles.
Leichner PK; Kwok CS
Med Phys; 1993; 20(2 Pt 2):529-34. PubMed ID: 8492761
[TBL] [Abstract][Full Text] [Related]
31. Radiation risk estimates after radiotherapy: application of the organ equivalent dose concept to plateau dose-response relationships.
Schneider U; Kaser-Hotz B
Radiat Environ Biophys; 2005 Dec; 44(3):235-9. PubMed ID: 16273381
[TBL] [Abstract][Full Text] [Related]
32. Three-dimensional heart dose reconstruction to estimate normal tissue complication probability after breast irradiation using portal dosimetry.
Louwe RJ; Wendling M; van Herk MB; Mijnheer BJ
Med Phys; 2007 Apr; 34(4):1354-63. PubMed ID: 17500466
[TBL] [Abstract][Full Text] [Related]
33. Biologically effective dose distribution based on the linear quadratic model and its clinical relevance.
Lee SP; Leu MY; Smathers JB; McBride WH; Parker RG; Withers HR
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):375-89. PubMed ID: 7673025
[TBL] [Abstract][Full Text] [Related]
34. Risk-adaptive optimization: selective boosting of high-risk tumor subvolumes.
Kim Y; Tomé WA
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1528-42. PubMed ID: 17126211
[TBL] [Abstract][Full Text] [Related]
35. Calculated and simulated effects of heterogeneous dose distributions in radiotherapy using the dose volume inhomogeneity corrected biological equivalent dose formula with special reference to prostate cancer.
Lennernäs B; Albertsson P; Edgren M; Nilsson S
Oncol Rep; 2007 Nov; 18(5):1299-303. PubMed ID: 17914588
[TBL] [Abstract][Full Text] [Related]
36. Effect of edema, relative biological effectiveness, and dose heterogeneity on prostate brachytherapy.
Wang JZ; Mayr NA; Nag S; Montebello J; Gupta N; Samsami N; Kanellitsas C
Med Phys; 2006 Apr; 33(4):1025-32. PubMed ID: 16696479
[TBL] [Abstract][Full Text] [Related]
37. Reporting and analyzing dose distributions: a concept of equivalent uniform dose.
Niemierko A
Med Phys; 1997 Jan; 24(1):103-10. PubMed ID: 9029544
[TBL] [Abstract][Full Text] [Related]
38. Biological effect of different IMRT delivery techniques: SMLC, DMLC, and helical tomotherapy.
Shaikh M; Burmeister J; Joiner M; Pandya S; Zhao B; Liu Q
Med Phys; 2010 Feb; 37(2):762-70. PubMed ID: 20229886
[TBL] [Abstract][Full Text] [Related]
39. Incorporating model parameter uncertainty into inverse treatment planning.
Lian J; Xing L
Med Phys; 2004 Sep; 31(9):2711-20. PubMed ID: 15487755
[TBL] [Abstract][Full Text] [Related]
40. A filtering approach based on Gaussian-powerlaw convolutions for local PET verification of proton radiotherapy.
Parodi K; Bortfeld T
Phys Med Biol; 2006 Apr; 51(8):1991-2009. PubMed ID: 16585841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
